NEW YORK, Oct. 11 – Luminex said on Thursday that a surprising surge in sales during the third-quarter will help the company report greater-than-expected revenues and a leaner loss than Wall Street had forecast for the period.

The Austin, Tex.-based bead-array developer said in a statement that revenues for the quarter ended Sept. 30 would be about $6.2 million, exceeding the $6.1 million offered by an analysts’ consensus estimate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.